Catherine Skari
-
Sep- 2023 -22 SeptemberNews
BLOOD TRAΝSFUSION THERAPY | FDA Approves Hemanext ONE®
This revolutionary technology sets a new standard in RBC processing and storage by limiting oxygen in the storage environment, thereby…
Read More » -
15 SeptemberScientific Literature
How I Τreat Non-Transfusion-Dependent β-Thalassemia
The intricate interplay of anemia and iron overload under the pathophysiological umbrella of ineffective erythropoiesis in non-transfusion-dependent β-thalassemia (NTDT) results…
Read More » -
14 SeptemberNews
WEBINAR | Haemoglobin Disorders and EU Health Policies, 21 September 2023
Designed for patients and their families, these webinars aim to foster national advocacy for the improvement of service delivery. The…
Read More » -
10 SeptemberScientific News
Corticosteroid Use in Pregnant Women with SCD Doubles Risk of Severe VOCs
According to a French study, corticosteroids used during pregnancy are a risk factor for more severe vaso-occlusive crises (VOCs) in…
Read More » -
1 SeptemberNews
CLINICAL NEWS | FDA Approves Luspatercept for First-line Treatment of Anemia in Lower-Risk MDS
The approval was based on interim results from the pivotal phase 3 COMMANDS trial (ClinicalTrials.gov Identifier: NCT03682536) that evaluated the efficacy…
Read More » -
Aug- 2023 -30 AugustNews
TIF European Health Policy Webinar Series | 21 September 2023
Designed for patients and their families, these webinars aim to foster national advocacy for the improvement of service delivery. The…
Read More » -
27 AugustTIF News
PUBLICATIONS | Nutrition Guidelines in Thalassemia & PKD
Nutrition holds a significant position in the lives of individuals afflicted with thalassaemia and other hereditary anaemias. As part of…
Read More » -
27 AugustNews
IN THE SPOTLIGHT | Explore Our Latest Work in the TIF Newsletter, August Edition
The remarkable collaborations and activities carried out in the past two months have been truly invigorating, and we eagerly anticipate…
Read More » -
25 August
-
24 AugustScientific Literature
Pregnancy-related Thromboembolism in Women with Sickle Cell Disease: An Analysis of National Medicaid Data
Pregnancy and sickle cell disease (SCD) both individually carry a risk of thromboembolism (TE). Pregnancy in people with SCD may…
Read More »
